---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-044154"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T03:07:13.294070+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical Q3 revenue down 4% to $11.5M; cuts FY24 guidance; workforce –25%

## Summary
- Net loss $4.7M ($0.14/share) vs $4.6M YoY; adjusted EBITDA loss $2.4M.
- Total revenue $11.5M (Advanced Energy -6% to $9.3M; OEM +3% to $2.2M).
- FY24 revenue guidance cut to $46.6-47.6M from prior $50.6-52.1M; net loss expected ~$25M.
- Raised ~$7M via registered direct offering of 3M shares + pre-funded warrants at $1.18/share.
- Reduced U.S. workforce ~25% for ~$4.3M annual savings; three directors resigned; COO appointed.

## SEC filing metadata
- accession: 0001493152-24-044154
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.02, 2.03, 3.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/0001493152-24-044154-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-044154
- JSON: https://secwatch.observer/filing/0001493152-24-044154.json
- Plain text: https://secwatch.observer/filing/0001493152-24-044154.txt

## Key facts
- Executive change
  Michael Geraghty resigned as Director at Apyx Medical Corp.
  - Action: resigned
  - Role: Director
  source text: On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/0001493152-24-044154-index.htm
- Executive change
  John Andres resigned as Director at Apyx Medical Corp.
  - Action: resigned
  - Role: Director
  source text: On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/0001493152-24-044154-index.htm
- Executive change
  Shawn D. Roman was appointed as Chief Operating Officer at Apyx Medical Corp.
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On November 6, 2024, the Board appointed Shawn D. Roman as the Chief Operating Officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/0001493152-24-044154-index.htm
- Executive change
  Craig Swandal resigned as Director at Apyx Medical Corp.
  - Action: resigned
  - Role: Director
  source text: On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/0001493152-24-044154-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.